No Data
No Data
Insiders Hold 63% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and They've Been Buying Recently
Insider Purchase: 10% Owner at $NVCT (NVCT) Buys 17,000 Shares
Nuvectis Pharma to Present at the 2024 Ladenburg Virtual Oncology Innovators & Investors Symposium
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug
S&P 500 Moves Lower; US Crude Oil Inventories Increase
No Data